Advertisement

Topics

Signet Laboratories, Inc. Company Profile

18:27 EDT 17th June 2018 | BioPortfolio

Signet Laboratories, Inc. (Signet, Dedham, MA) is a leading medical diagnostics/research company specializing in the development of monoclonal antibodies and diagnostics assays for cancer, infectious disease, and neurodegenerative disease. Signet was created in 1989 as a commercial spinout of Johnson & Johnson’s Cambridge Research Laboratories, Inc. (CRL, Cambridge, MA). Signet’s mission is to deliver safe and efficacious medicines to critical areas of medical need. Signet’s novel technologies will fundamentally change the existing drug discovery process, providing for significant decreases in both the cost and time to bring new diagnostic and therapeutic entities to market. Signet is committed to developing technical and pharmaceutical solutions that advance the medical community’s ability to successfully diagnose and treat patient populations

Location

180 Rustcraft Road, Suite 140
Dedham
Massachusetts
02026
United States of America

Contact

Phone: 781.329.7919
Fax: 781.461.2456
Email: sales@signetlabs.com


News Articles [238 Associated News Articles listed on BioPortfolio]

Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses base...

Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study

Reviewing Impax Laboratories

Impax Laboratories and Corcept Therapeutics are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, in...

Critical Comparison: Impax Laboratories

Impax Laboratories and Innocoll are both small-cap pharmaceuticals - nec companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk,...

Zacks: Brokerages Anticipate Impax Laboratories Inc (IPXL) Will Announce Earnings of $0.12 Per Share

Analysts forecast that Impax Laboratories Inc will post earnings per share of $0.12 for the current quarter, Zacks reports. Five analysts have made estimates for Impax Laboratories' earnings.

Brokers Issue Forecasts for Impax Laboratories Inc's Q1 2018 Earnings

Impax Laboratories Inc - Analysts at SunTrust Banks issued their Q1 2018 earnings estimates for Impax Laboratories in a report issued on Wednesday. SunTrust Banks analyst J. Boris expects that the spe...

Impax Laboratories (IPXL) versus AzurRx BioPharma (AZRX) Head-To-Head Analysis

Impax Laboratories and AzurRx BioPharma are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, ...

Leading Pharma gets $40 million infusion for growth

David SalazarLeading Pharma said that its growth capital, led by Signet Healthcare Partners and Crestline Investors, will be used to expand the Fairfield, N.J.-based company’s pipeline and ...

PubMed Articles [182 Associated PubMed Articles listed on BioPortfolio]

ACTH-Cell Pituitary Adenoma With Signet Ring Cells: A Rare Case Report and Review of The Literature.

Here, we present a case of pituitary adenoma producing adrenocorticotropic hormone (ACTH) in a 19-year-old woman. The patient was admitted to neurosurgery clinic because of a headache and decreased vi...

Molecular Characterization of Colorectal Signet-Ring Cell Carcinoma Using Whole-Exome and RNA Sequencing.

Signet-ring cell carcinoma (SRCC) is a very rare subtype of colorectal adenocarcinoma (COAD) with a poor clinical prognosis. Although understanding key mechanisms of tumor progression in SRCCs is crit...

An Epithelioid Smooth Muscle Neoplasm Mimicking a Signet Ring Cell Carcinoma in the Ovary.

A 53-yr-old woman who presented with elevated renal indices was discovered to have a 4.5 cm right renal mass and an incidental 9.7 cm left ovarian mass on imaging studies. She underwent a partial ...

Survival in signet ring cell carcinoma varies based on primary tumor location: a Surveillance, Epidemiology, and End Results database analysis.

The aim of this study was to investigate the survival of patients with signet ring cell carcinoma (SRCC) based on primary tumor location.

The Impact of Epidemiological Factors and Treatment Interventions on Survival in Patients With Signet Ring Cell Carcinoma of the Pancreas.

Primary pancreatic signet ring cell carcinoma (SRCC) is a rare histologic variant of pancreatic carcinoma. A population-based analysis of pancreatic SRCC was performed to determine the predictive effe...

Clinical Trials [256 Associated Clinical Trials listed on BioPortfolio]

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

This is a randomized, multicenter, controlled study to compared the Efficacy and Safety of XELOX combined with Apatinib versus XELOX as post-operative chemotherapy in locally advanced gast...

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Companies [954 Associated Companies listed on BioPortfolio]

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

Rainbow Scientific, Inc.

Rainbow Scientific, Inc. markets, sells, and distributes state-of-the-art medical diagnostic test kits to both research and clinical laboratories. From our Windsor, Connecticut location, we are commit...

Bedford Laboratories

Bedford Laboratories supplies the U.S. and International markets with multisource and specialty injectable products offering a broad range of multisource injectables across multiple therapeutic classe...

Carma Laboratories Inc.

For more than 70 years, Milwaukee-based Carma Laboratories has manufactured Carmex brand lip balm. Carmex products are available at most U.S. retailers and online. For more information, contact Carma ...

Nutramax Laboratories Inc

Nutramax Laboratories provides nutritional products for people, animals, and plants. Nutramax Laboratories leads dietary supplement manufacturers in researching products and in setting high manufactur...

More Information about "Signet Laboratories, Inc." on BioPortfolio

We have published hundreds of Signet Laboratories, Inc. news stories on BioPortfolio along with dozens of Signet Laboratories, Inc. Clinical Trials and PubMed Articles about Signet Laboratories, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Signet Laboratories, Inc. Companies in our database. You can also find out about relevant Signet Laboratories, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record